Printer Friendly

BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR THIRD QUARTER

 BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES
 AND EARNINGS FOR THIRD QUARTER
 WATERTOWN, Mass., Oct. 27 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today released results for its third quarter ended Sept. 30, 1992.
 Net sales for the third quarter increased 37 percent to $81,861,000 from the previous year's $59,898,000. Net earnings for the quarter increased 40 percent to $15,205,000, or 15 cents per share, from $10,886,000, or 12 cents per share, in the previous year.
 Net sales for the nine months ended Sept. 30, 1992 increased 39 percent to $230,812,000 compared to $166,237,000 for the same period last year. Net earnings for the nine months increased 32 percent to $41,045,000, or 42 cents per share, compared to $31,151,000, or 33 cents per share, in the previous year.
 Pete Nicholas, co-chairman and chief executive officer, said, "Business conditions continue to be favorable in each of the markets that we serve. Solid growth again was experienced across all of the company's divisions. We expect this trend to continue in the fourth quarter and into 1993."
 Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices. The company's products are used in a broad range of interventional medical specialties including cardiology, gastroenterology, pulmonary medicine, radiology, urology, and vascular surgery.
 BOSTON SCIENTIFIC CORPORATION
 (in thousands, except per share amounts)
 Three Months Ended Nine Months Ended
 September 30, September 30,
 (Unaudited) 1992 1991 1992 1991
 Net sales $81,861 $59,898 $230,812 $166,237
 Cost of products sold 29,771 21,252 84,657 57,366
 Gross Profit 52,090 38,646 146,155 108,871
 Selling, general and
 administrative
 expenses 23,249 17,560 66,020 48,044
 Research & development
 expenses 4,572 2,726 12,773 7,978
 Total 27,821 20,286 78,793 56,022
 Income from operations 24,269 18,360 67,362 52,849
 Other income (expense)
 Other income 1,121 171 1,775 440
 Interest expense (680) (650) (2,183) (2,311)
 Other expense (13) (180) (292) (326)
 Income before income
 taxes and
 extraordinary credit 24,697 17,701 66,662 50,652
 Income taxes 9,492 6,880 25,617 19,688
 Income before
 extraordinary credit 15,205 10,821 41,045 30,964
 Extraordinary income
 tax credit from
 utilization of NOL
 carryforwards --- 65 --- 187
 Net income $15,205 $10,886 $41,045 $31,151
 Net income per share 15 cents 12 cents 42 cents 33 cents
 Weighted average
 number of shares 101,818,850 94,148,575 97,731,769 94,148,575
 -0- 10/27/92
 /CONTACT: Larry Best of Boston Scientific Corporation, 617-972-4450/
 (BSX) CO: Boston Scientific Corporation ST: Massachusetts IN: MTC SU: ERN


DD -- NE006 -- 5172 10/27/92 08:06 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 27, 1992
Words:467
Previous Article:COMPTEK ANNOUNCES CELLULAR DATAMOVER~ TO BE TESTED BY NYNEX
Next Article:ROBERT HALF INTERNATIONAL INC. REPORTS 21 PERCENT INCREASE IN THIRD QUARTER EARNINGS
Topics:


Related Articles
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR SECOND QUARTER
BOSTON SCIENTIFIC CORPORATION REPORTS CONTINUED GROWTH IN SALES AND EARNINGS FOR YEAR ENDED DECEMBER 31, 1992
BOSTON SCIENTIFIC CORPORATION ANNOUNCES SALES GROWTH FOURTH QUARTER AND YEAR 1993
BOSTON SCIENTIFIC CORPORATION REPORTS CONTINUED GROWTH IN SALES AND EARNINGS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 1993
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR FIRST QUARTER
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR THIRD QUARTER
Boston Scientific Corporation Addresses Third Quarter Growth
Boston Scientific Corporation Addresses Third Quarter Revenue Growth
Boston Scientific Corporation Announces Results For Third Quarter
Boston Scientific Announces Third Quarter Results.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters